A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer

Authors: Ho, Alice Y., Barker, Christopher A., Arnold, Brittany B., Powell, Simon N., Hu, Zishuo I., Gucalp, Ayca, Lebron‐Zapata, Lizza, Wen, Hannah Y., Kallman, Cindy, D'Agnolo, Alessandro, Zhang, Zhigang, Flynn, Jessica, Dunn, Samantha A., McArthur, Heather L.

Source: Cancer. 126(4):850-860

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097872693.0x000001&indx=1&recIds=ETOCvdc_100097872693.0x000001

Radiotherapy in the setting of breast reconstruction: types, techniques, and timing

Authors: Ho, Alice Y, Hu, Zishuo I, Mehrara, Babak J, Wilkins, Edwin G

Source: In The Lancet Oncology December 2017 18(12):e742-e753

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Authors: Drilon, Alexander, Hu, Zishuo I., Lai, Gillianne G. Y., Tan, Daniel S. W.

Source: Nature reviews.Clinical oncology. 15(3):151-167

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130015254.0x000001&indx=1&recIds=ETOCvdc_100130015254.0x000001

Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer

Authors: Hu, Zishuo I., Ho, Alice Y., McArthur, Heather L.

Source: International journal of radiation oncology, biology, physics. 99(1):153-164

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100061029726.0x000001&indx=1&recIds=ETOCvdc_100061029726.0x000001

Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer

Authors: Levy, Benjamin, Hu, Zishuo I., Cordova, Kristen N., Close, Sandra, Lee, Karen, Becker, Daniel

Source: Oncologist. 21(9):1121-1130

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN608061020&indx=1&recIds=ETOCRN608061020

Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations

Authors: Hu, Zishuo I., Miettinen, Markku, Quezado, Martha, Lebensohn, Alexandra P., Aldape, Kenneth, Agra, Maria, Wagner, Cathy, Mallory, Yvonne, Hassan, Raffit, Ghafoor, Azam

Source: In Journal of Thoracic Oncology March 2022 17(3):461-466

Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin‐targeted therapies.

Authors: Hu, Zishuo I.¹ (AUTHOR), Ghafoor, Azam¹ (AUTHOR), Sengupta, Manjistha¹ (AUTHOR), Hassan, Raffit¹ (AUTHOR) hassanr@mail.nih.gov

Source: Cancer (0008543X). Apr2021, Vol. 127 Issue 7, p1010-1020. 11p.

Subject Terms: *IPILIMUMAB, *IMMUNE checkpoint inhibitors, *PEMETREXED, *PLEURA diseases, *MESOTHELIOMA

Company/Entity: UNITED States. Food & Drug Administration

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Erratum: Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Authors: Drilon, Alexander, Hu, Zishuo I., Lai, Gillianne G. Y., Tan, Daniel S. W.

Source: Nature reviews.Clinical oncology. 15(3):150-150

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130015317.0x000001&indx=1&recIds=ETOCvdc_100130015317.0x000001

Immunotherapy in Breast Cancer: the New Frontier.

Authors: Hu, Zishuo I., McArthur, Heather L.

Source: Current Breast Cancer Reports; Jun2018, Vol. 10 Issue 2, p35-40, 6p

Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1Mutations

Authors: Hu, Zishuo I., Miettinen, Markku, Quezado, Martha, Lebensohn, Alexandra P., Aldape, Kenneth, Agra, Maria, Wagner, Cathy, Mallory, Yvonne, Hassan, Raffit, Ghafoor, Azam

Source: Journal of Thoracic Oncology; 20210101, Issue: Preprints

Erratum: Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Authors: Drilon, Alexander, Hu, Zishuo I., Lai, Gillianne G. Y., Tan, Daniel S. W.

Source: Nature Reviews Clinical Oncology; March 2018, Vol. 15 Issue: 3 p150-150, 1p